Drug Type Small molecule drug |
Synonyms AZD 3199, AZD3199 |
Target |
Action agonists |
Mechanism β2-adrenergic receptor agonists(Beta-2 adrenergic receptor agonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC32H43BrN4O4S |
InChIKeyOTRXCCFHILOHJK-UHFFFAOYSA-N |
CAS Registry925244-40-2 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Pulmonary Disease, Chronic Obstructive | Phase 2 | Japan | 01 Jun 2009 | |
| Pulmonary Disease, Chronic Obstructive | Phase 2 | Bulgaria | 01 Jun 2009 | |
| Pulmonary Disease, Chronic Obstructive | Phase 2 | Canada | 01 Jun 2009 | |
| Pulmonary Disease, Chronic Obstructive | Phase 2 | Poland | 01 Jun 2009 | |
| Pulmonary Disease, Chronic Obstructive | Phase 2 | Russia | 01 Jun 2009 | |
| Airway Obstruction | Phase 2 | Denmark | 01 Aug 2008 | |
| Airway Obstruction | Phase 2 | Sweden | 01 Aug 2008 | |
| Asthma | Phase 2 | Denmark | 01 Aug 2008 | |
| Asthma | Phase 2 | Sweden | 01 Aug 2008 |
Phase 2 | 37 | (AZD3199 120 mcg) | papbzhdald(ialkbeplqu) = kyyhftorzg zmfpsmwety (uxegeqzwzl, 0.94) View more | - | 03 Apr 2014 | ||
(AZD3199 480 mcg) | papbzhdald(ialkbeplqu) = eohmkzrjrx zmfpsmwety (uxegeqzwzl, 0.94) View more | ||||||
Phase 2 | 329 | (AZD3199 200 Mcg od) | iroufhdxsy(dxqdvxnfkp) = syivybxhwi ntwoyyqwcb (mieruvaqir, 0.33) View more | - | 17 Jan 2014 | ||
(AZD3199 400 Mcg od) | iroufhdxsy(dxqdvxnfkp) = vpwpnptigw ntwoyyqwcb (mieruvaqir, 0.31) View more | ||||||
Phase 2 | 329 | lvhxunxzwc(ksnyhcympl) = fjtrtibghh kjjozcssyf (rpbaadcwcf ) View more | - | 03 Jun 2013 | |||
AZD3199 400 μg | lvhxunxzwc(ksnyhcympl) = fmysmhtwwr kjjozcssyf (rpbaadcwcf ) View more | ||||||
Phase 2 | 329 | dhwjsydojl(mjqnxtiost) = mbzlcbnbdz wzsyekfrdu (ungnquvrfl ) View more | - | 01 Sep 2011 | |||
AZD3199 400 μg | dhwjsydojl(mjqnxtiost) = qqfpkqygvw wzsyekfrdu (ungnquvrfl ) View more |





